These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 28365965)

  • 1. Polymorphisms of survivin -31 G/C gene are associated with risk of urothelial carcinoma in Serbian population.
    Bogdanovic L; Lazic M; Bogdanovic J; Soldatovic I; Nikolic N; Radunovic M; Radojevic-Skodric S; Milasin J; Basta-Jovanovic G
    J BUON; 2017; 22(1):270-277. PubMed ID: 28365965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between survivin gene promoter -31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population.
    Wang YH; Chiou HY; Lin CT; Hsieh HY; Wu CC; Hsu CD; Shen CH
    Urology; 2009 Mar; 73(3):670-4. PubMed ID: 19038421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of polymorphism in the survivin gene promoter as a potential risk factor for head and neck cancers development.
    Kostić M; Nikolić N; Ilić B; Carkić J; Milenković S; Vukadinović M
    Srp Arh Celok Lek; 2013; 141(5-6):304-7. PubMed ID: 23858797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin gene promoter -31 G/C polymorphism is associated with Wilms tumor susceptibility in Serbian children.
    Radojevic-Skodric S; Basta-Jovanovic G; Brasanac D; Nikolic N; Bogdanovic L; Milicic B; Milasin J
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):e310-4. PubMed ID: 22858571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between survivin gene polymorphisms and the susceptibility to colon cancer development in the Turkish population.
    Yamak N; Yaykasli KO; Yilmaz U; Eroz R; Uzunlar AK; Ankarali H; Sahiner C; Baltaci D
    Asian Pac J Cancer Prev; 2014; 15(20):8963-7. PubMed ID: 25374237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of survivin promoter polymorphisms with inflammatory bowel disease and response to antitumor necrosis factor therapy.
    Rapti E; Gazouli M; Legaki E; Karamanolis G; Thomas D; Marinos E; Papaconstantinou I
    Genet Test Mol Biomarkers; 2015 Jun; 19(6):339-43. PubMed ID: 25918954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of TNF-
    Wu CC; Huang YK; Huang CY; Shiue HS; Pu YS; Su CT; Lin YC; Hsueh YM
    Biomed Res Int; 2018; 2018():3148137. PubMed ID: 29951534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epistatic interaction between adiponectin and survivin gene polymorphisms in endometrial carcinoma.
    Aminimoghaddam S; Shahrabi-Farahani M; Mohajeri-Tehrani M; Amiri P; Fereidooni F; Larijani B; Shafiee G; Amoli MM
    Pathol Res Pract; 2015 Apr; 211(4):293-7. PubMed ID: 25613698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XRCC1 Polymorphisms and Urinary 8-Hydroxydeoxyguanine Levels Are Associated with Urothelial Carcinoma.
    Chiang CI; Huang YL; Huang CY; Shiue HS; Chen WJ; Pu YS; Lin YC; Hsueh YM
    PLoS One; 2015; 10(5):e0124066. PubMed ID: 25938407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma.
    Wu CC; Huang YK; Chung CJ; Huang CY; Pu YS; Shiue HS; Lai LA; Lin YC; Su CT; Hsueh YM
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):30-6. PubMed ID: 23727622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin gene promoter polymorphism -31G/C as a risk factor for keratocystic odontogenic tumor development.
    Andric M; Nikolic N; Boskovic M; Milicic B; Skodric S; Basta Jovanovic G; Milasin J
    Eur J Oral Sci; 2012 Feb; 120(1):9-13. PubMed ID: 22288915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant association of caveolin-1 (CAV1) genotypes with upper urothelial tract cancer.
    Chang WS; Lin SS; Li FJ; Tsai CW; Li LY; Lien CS; Liao WL; Wu HC; Tsai CH; Shih TC; Bau DT
    Anticancer Res; 2013 Nov; 33(11):4907-12. PubMed ID: 24222128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes gene polymorphisms, NNK metabolites levels and urothelial carcinoma.
    Chung CJ; Pu YS; Shiue HS; Lee HL; Lin P; Yang HY; Su CT; Hsueh YM
    Toxicol Lett; 2013 Jan; 216(1):16-22. PubMed ID: 23142425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of
    Kafadar D; Yaylim I; Kafadar AM; Cacina C; Ergen A; Kaynar MY; Isbir T
    Anticancer Res; 2018 Oct; 38(10):5991-5998. PubMed ID: 30275230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population.
    Bayram S; Akkız H; Bekar A; Akgöllü E
    Cancer Epidemiol; 2011 Dec; 35(6):555-9. PubMed ID: 21296634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary evidence of polymorphisms of cell cycle regulatory genes and their roles in urinary tract urothelial cancer susceptibility and prognosis in a Taiwan population.
    Lin YC; Hour TC; Tsai YC; Huang SP; Wu WJ; Chen CH; Pu YS; Chung SD; Huang CY
    Urol Oncol; 2017 Sep; 35(9):543.e7-543.e16. PubMed ID: 28668478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer risk.
    Liarmakopoulos E; Theodoropoulos G; Vaiopoulou A; Rizos S; Aravantinos G; Kouraklis G; Nikiteas N; Gazouli M
    Mol Med Rep; 2013 Mar; 7(3):887-92. PubMed ID: 23258739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma.
    Cheng ZJ; Hu LH; Huang SJ
    Ai Zheng; 2008 Mar; 27(3):258-63. PubMed ID: 18334114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible nitric oxide synthase promoter polymorphism, cigarette smoking, and urothelial carcinoma risk.
    Shen CH; Wang YH; Wang WC; Jou YC; Hsu HS; Hsieh HY; Chiou HY
    Urology; 2007 May; 69(5):1001-6. PubMed ID: 17482959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer.
    Wang YH; Yeh SD; Wu MM; Liu CT; Shen CH; Shen KH; Pu YS; Hsu LI; Chiou HY; Chen CJ
    J Hazard Mater; 2013 Nov; 262():1139-46. PubMed ID: 23009795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.